IP Verse

Novartis Pharmaceuticals Corporation vs Plexxikon Inc.

The detailed information for PTAB case with proceeding number IPR2018-01287 filed by Novartis Pharmaceuticals Corporation against Plexxikon Inc. on Jun 18, 2018. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2018-01287
Filing Date: Jun 18, 2018
Petitioner: Novartis Pharmaceuticals Corporation
Respondent: Plexxikon Inc.
Status: Institution Denied
Respondent Application Number: 15048851
Respondent Tech Center: 1600
Respondent Patent Number: 9469640
Institution Decision Date: Jan 16, 2019

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Trial Instituted Document	Jan 16, 2019	PAPER	BOARD
Order Granting Petitioner's Motion for Admission Pro Hac Vice of Thomas P. Steindler	Nov 30, 2018	PAPER	BOARD
Order Granting Petitioner's Motion for Admission Pro Hac Vice of David Mlaver	Nov 30, 2018	PAPER	BOARD
Order Conditionally Granting Patent Owner's Motion for Admission Pro Hac Vice of Anna E. Dwyer	Nov 30, 2018	PAPER	BOARD
Conduct of the Proceeding	Nov 19, 2018	PAPER	BOARD
Patent Owner's Preliminary Response	Oct 18, 2018	PAPER	PATENT OWNER
July 16, 2016 Interview Summary filed in the prosecution of U.S. Patent No. 9,469,640	Oct 18, 2018	EXHIBIT	PATENT OWNER
June 29, 2012 Office action filed in the prosecution of U.S. Application 12/669,450	Oct 18, 2018	EXHIBIT	PATENT OWNER
February 19, 2016 Preliminary Amendment filed in the prosecution of U.S. Patent No. 9,469,640	Oct 18, 2018	EXHIBIT	PATENT OWNER
James Tsai, et al., ¿¿¿Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity¿¿¿, PNAS (2008) 105:8, 3041-3046.	Oct 18, 2018	EXHIBIT	PATENT OWNER
John C. Stellwagen et al., ¿¿¿Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup¿¿¿, Bioorganic & Medicinal Chemistry Letters 21 (2011) 4436-4440.	Oct 18, 2018	EXHIBIT	PATENT OWNER
Bio of Anna E. Dwyer	Oct 18, 2018	EXHIBIT	PATENT OWNER
Patent Owner's Updated Exhibit List	Oct 18, 2018	PAPER	PATENT OWNER
Tara R. Rheault, et al., ¿¿¿Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors¿¿¿, ACS Medicinal Chemistry Letters (2013), 4, 358-362.	Oct 18, 2018	EXHIBIT	PATENT OWNER
Motion for Pro Hac Vice Admission Under 37 C.F.R. 42.10	Oct 18, 2018	PAPER	PATENT OWNER
Declaration of Anna E. Dwyer in Support of Motion for Pro Hac Vice Admission Under 37 C.F.R. 42.10	Oct 18, 2018	EXHIBIT	PATENT OWNER
Notice of Accord Filing Date	Jul 19, 2018	PAPER	BOARD
Patent Owner's Power of Attorney	Jun 29, 2018	PAPER	PATENT OWNER
Patent Owner's Mandatory Notices Pursuant to 37 C.F.R. 42.8	Jun 29, 2018	PAPER	PATENT OWNER
Prosecution History, October 4, 2013 Office Action	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, April 3, 2015 Office Action	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, September 3, 2015 Office Action	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, Examiner¿¿¿s Summary of January 15, 2016 Interview	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, Statement of Substance of Interview	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, February 19, 2016 Preliminary Amendment	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, April 18, 2016 Office Action	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, September 2, 2016 Notice of Allowance	Jun 18, 2018	EXHIBIT	PETITIONER
H¿¿mmerle et al., A guideline for the arylation of positions 4 and 5	Jun 18, 2018	EXHIBIT	PETITIONER
Li and Gribble, PALLADIUM IN HETEROCYCLIC CHEMISTRY	Jun 18, 2018	EXHIBIT	PETITIONER
Wu et al., U.S. Patent No. 9,469,640	Jun 18, 2018	EXHIBIT	PETITIONER
Declaration of Phil S. Baran, Ph.D.	Jun 18, 2018	EXHIBIT	PETITIONER
Phil S. Baran, Ph.D CV	Jun 18, 2018	EXHIBIT	PETITIONER
U.S. Application No. 12/669,450	Jun 18, 2018	EXHIBIT	PETITIONER
Tara R. Rheault, U.S. Patent No. 7,994,185	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, June 5, 2014 Notice of Abandonment	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, August 3, 2015 Amendment and Reply	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, April 18, 2016 Notice of Abandonment	Jun 18, 2018	EXHIBIT	PETITIONER
Prosecution History, July 20, 2016 Amendment and Response	Jun 18, 2018	EXHIBIT	PETITIONER
Martin et al., ¿¿¿Palladium-Catalyzed Suzuki-Miyaura Cross-Coupling Reactions Employing Dialkylbiaryl Phosphine Ligands	Jun 18, 2018	EXHIBIT	PETITIONER
D¿¿fert et al., Suzuki-Miyaura Cross-Coupling of Unprotected	Jun 18, 2018	EXHIBIT	PETITIONER
Kinzel et al., A New Palladium Precatalyst Allows for the Fast Suzuki-Miyaura Coupling	Jun 18, 2018	EXHIBIT	PETITIONER
Jedin¿¿k et al., The Suzuki¿¿¿Miyaura Cross-Coupling Reaction of Halogenated Aminopyrazoles	Jun 18, 2018	EXHIBIT	PETITIONER
Elizabeth Tyrrell and Phillip Brookes, The Synthesis and Applications of Heterocyclic Boronic Acids	Jun 18, 2018	EXHIBIT	PETITIONER
Cox et al., Protodeboronation of heteroaromatic, vinyl and cyclopropyl boronic acids	Jun 18, 2018	EXHIBIT	PETITIONER
Suzuki, Cross-Coupling Reactions of Organoboranes	Jun 18, 2018	EXHIBIT	PETITIONER
Power of Attorney	Jun 18, 2018	PAPER	PETITIONER
PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 9,469,640	Jun 18, 2018	PAPER	PETITIONER
Declaration of Thomas P. Steindler in Support of Petitioners Motion for Admission Pro Hac Vice	Jun 18, 2018	PAPER	PETITIONER
Declaration of David Mlaver in Support of Petitioners Motion for Admission Pro Hac Vice	Jun 18, 2018	PAPER	PETITIONER
PETITIONER¿¿¿S MOTION FOR ADMISSION PRO HAC VICE OF THOMAS P. STEINDLER	Jun 18, 2018	PAPER	PETITIONER
of Petitioners Motion for Admission Pro Hac Vice of David Mlaver	Jun 18, 2018	PAPER	PETITIONER